iRhythm Technologies, Inc. (IRTC) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in San Francisco, CA, United States. The current CEO is Quentin S. Blackford.
IRTC has IPO date of 2016-10-20, 2,000 full-time employees, listed on the NASDAQ Global Select, a market capitalization of $3.98B.
iRhythm Technologies, Inc. is a digital healthcare company headquartered in San Francisco that specializes in ambulatory electrocardiogram (ECG) monitoring solutions for patients at risk of arrhythmias in the United States. The company's flagship Zio service combines wire-free, patch-based wearable biosensors with a cloud-based analytics platform to enable physicians to continuously monitor patients and diagnose cardiac arrhythmias. Its Zio XT and AT monitors are single-use, wearable patches that record patient heartbeats and ECG data for clinical analysis. iRhythm also collaborates with Verily Life Sciences to develop next-generation atrial fibrillation detection and monitoring products, positioning itself at the intersection of wearable technology and cardiac care.
